Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases

ACS Publications·Dec 6

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

Researchers are exploring the use of nanovaccines to advance long-lasting immunity against infectious diseases. The development of nanovaccines is being investigated for various applications, including respiratory, veterinary, and gastrointestinal diseases, with some studies focusing on specific diseases such as tuberculosis. The use of nanomaterials and nanoparticles is being studied for their potential to enhance immunization strategies and elicit effective immune responses.

Full coverage

Nanoparticle-Based Antigen Delivery: Advancing Immunization Strategies against Infectious Pathogens

Science Partner Journals·Jul 3

Advances and prospects of respiratory mucosal vaccines: mechanisms, technologies, and clinical applications

Nature·Nov 12

Advancing veterinary vaccines design through trained immunity insights

Frontiers·Dec 31

Eliciting B cell immunity against infectious diseases using nanovaccines

Nature·Nov 16

Self-Adjuvanting Adenoviral Nanovaccine for Effective T-Cell-Mediated Immunity and Long-Lasting Memory Cell Activation against Tuberculosis

ACS Publications·Oct 28

Nanomaterial Adjuvants for Veterinary Vaccines: Mechanisms and Applications

Science Partner Journals·Jul 8

Nanovaccines in gastrointestinal cancers

Frontiers·Dec 1

Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models

Nature·Mar 25

View original report at ACS Publications ↗

Fetching the latest headlines…